HeXun Biosciences Co., Ltd.

NT$40.10As of Sun 8 Nov 2026, 12:00 UTC
TPEx:6986Healthcare
Country Taiwan
PE (Fwd) •••
TSR 3Y CAGR (19.26%)
Div yield 0.55%
ROE 13.26%
Biotechnology
Beta (5Y) 0.07
PE TTM 15.91
TSR TTM (29.70%)
Mkt cap NT$2.091B
ROIC 39.60%
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$50
25.49%
(79.51%)
Hold 9|12|11|0|8
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.40
0.43
0.45
0.46
1.37%
10.50%
19.71%
13.55%
RevenueNT$M
105.6
107.7
112.3
118.1
14.98%
14.13%
12.29%
16.01%
Peers (US$63.14M)
Cap (US$)
PE
59.75M
139.8x
Capital
TTM
5Y
10Y
Leveragex
0.276
0.871
0.659
EBIT/Intx
0.127
0.476
0.411
Own earn%
(43.65)
(119.84)
(104.84)
Sh yield%
28.00
26.51
27.92
Owners
Insiders/Inst%
0.17
80.08
Short interest%
3.43
SBC / revenue%
5.48
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
18
Op margin range%
10–18
$1 testx
—
Incr. ROIC%
8